RMC No. 108-2024: Clarifying Tax Exemption of Microinsurance Mutual Benefit Associations on Income Received

RMC No. 108-2024 clarifies that Microinsurance Mutual Benefit Associations (Mi-MBAs) registered and certified are exempt from income tax on income received for member benefits. Microinsurance Mutual Benefit Associations (Mi-MBAs) can now confidently operate without concern for income taxation, provided they comply with registration and certification requirements. Income received by these associations for the exclusive benefit […]

RMC No. 129-2022: Updates to VAT-Exempt Medicines List Affecting Mental Health Prescriptions

RMC No. 129-2022 updates the VAT-exempt medicines list under the CREATE Act, removing certain mental health medicines and requiring businesses to apply 12% VAT immediately. Businesses in the pharmaceutical sector, healthcare providers, and distributors must take immediate note: certain medicines previously exempt from VAT under Republic Act No. 11534 (CREATE Act) are now removed from […]

RMC No. 112-2022: FDA-Endorsed Updates to VAT-Exempt Medicines Affecting Tuberculosis Treatments

RMC No. 112-2022 updates the VAT-exempt medicines list under the CREATE Act, adding tuberculosis medicines and removing COVID-19 medicines, affecting tax compliance for healthcare providers. Businesses in the pharmaceutical and healthcare sectors must immediately update their records and compliance processes due to the newly endorsed changes to the VAT-exempt medicines list. Certain medicines prescribed for […]

RMC No. 57-2022: VAT Exemption Expanded to Include Hypertension, Diabetes, and COVID-19 Medicines

RMC No. 57-2022 updates the VAT-exempt list under the CREATE Act to include medicines for hypertension, diabetes, and COVID-19, requiring businesses to adjust invoicing and VAT reporting. Businesses and healthcare providers must immediately account for the updated VAT-exempt status of certain medicines for hypertension, diabetes, and COVID-19, effective from April 27, 2022. Failure to recognize […]

RMC No. 115-2021: Endorsement of Updated VAT-Exempt COVID-19 Medicines List Under RA 11534

RMC No. 115-2021 endorses the updated list of VAT-exempt COVID-19 vaccines and drugs under RA 11534. Businesses must apply VAT exemption immediately and maintain proper documentation. Businesses and healthcare providers must immediately take note of the updated VAT-exempt status for certain COVID-19 medicines under Republic Act No. 11534 (Corporate Recovery and Tax Incentives for Enterprises, […]

RMC No. 103-2021: Updated List of VAT-Exempt Medicines and COVID-19 Drugs for Immediate Compliance

RMC No. 103-2021 publishes updated VAT-exempt lists of medicines for hypertension, cancer, kidney diseases, and COVID-19 drugs, requiring immediate compliance for affected businesses. Businesses and taxpayers dealing with pharmaceutical products and COVID-19 treatments must immediately review the updated VAT-exempt lists published by the FDA and DOH. This update, under RMC No. 103-2021, supplements prior guidelines […]

RR No. 21-2002: Mandatory Financial Statement Compliance for Philippine Tax Filers

RR No. 21-2002 mandates descriptive, compliant financial statements for all annual tax filings, with auditor certification and record retention to avoid penalties. Businesses, professionals, and tax-exempt entities must ensure their financial statements meet detailed descriptive and procedural requirements when filed with the BIR. RR No. 21-2002 imposes strict standards for the preparation and submission of […]